Predicting the incidence and timing of central nervous system disease in metastatic melanoma: Implications for surveillance and preventative therapy - 13/01/18

Gary B. Deutsch, MD, MPH ^{a, ⁎} , Richard Tyrell, MD ^a, Samuel Yost, BA ^b, Mariel B. Deutsch, MD ^c, Garni Barkhoudarian, MD ^b, Daniel F. Kelly, MD ^b, Mark B. Faries, MD ^d

^a Hofstra-Northwell School of Medicine Uniondale, New York, New York 

^d Donald L. Morton, MD, Melanoma Research Program, New York, New York 

^b Brain Tumor Center, New York, New York 

^c Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York 

^∗Correspondence to: Gary B. Deutsch, MD, MPH, Hofstra-Northwell School of Medicine, 450 Lakeville Road, Lake Success, NY 11042Hofstra-Northwell School of Medicine450 Lakeville RoadLake SuccessNY11042